These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 16334139)

  • 1. Cyclooxygenase-2 protein expression in relation to apoptotic potential and its prognostic significance in bladder urothelial carcinoma.
    Diamantopoulou K; Lazaris A; Mylona E; Zervas A; Stravodimos K; Nikolaou I; Athanassiadou S; Nakopoulou L
    Anticancer Res; 2005; 25(6C):4543-9. PubMed ID: 16334139
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of laminin-5 gamma2 chain and its prognostic significance in urothelial carcinoma of urinary bladder: association with expression of cyclooxygenase 2, epidermal growth factor receptor [corrected] and human epidermal growth factor receptor [corrected] 2.
    Kiyoshima K; Oda Y; Kinukawa N; Naito S; Tsuneyoshi M
    Hum Pathol; 2005 May; 36(5):522-30. PubMed ID: 15948119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclooxygenase-2 expression on urothelial and inflammatory cells of cystoscopic biopsies and urine cytology as a possible predictive marker for bladder carcinoma.
    Moussa M; Omran Z; Nosseir M; Lotfy A; Swellam T
    APMIS; 2009 Jan; 117(1):45-52. PubMed ID: 19161536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of cyclooxygenase-2 in urothelial carcinoma in conjunction with tumor-associated-macrophage infiltration, hypoxia-inducible factor-1alpha expression, and tumor angiogenesis.
    Chen WT; Hung WC; Kang WY; Huang YC; Su YC; Yang CH; Chai CY
    APMIS; 2009 Mar; 117(3):176-84. PubMed ID: 19245590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Motility-related protein 1 (MRP-1/CD9) expression in urothelial bladder carcinoma and its relation to tumor recurrence and progression.
    Mhawech P; Herrmann F; Coassin M; Guillou L; Iselin CE
    Cancer; 2003 Oct; 98(8):1649-57. PubMed ID: 14534881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nuclear hTERT immunohistochemical expression is associated with survival of patients with urothelial bladder cancer.
    Mavrommatis J; Mylona E; Gakiopoulou H; Stravodimos C; Zervas A; Giannopoulos A; Nakopoulou L
    Anticancer Res; 2005; 25(4):3109-16. PubMed ID: 16080574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apoptosis-associated markers and clinical outcome in human oral squamous cell carcinomas.
    Kato K; Kawashiri S; Yoshizawa K; Kitahara H; Yamamoto E
    J Oral Pathol Med; 2008 Jul; 37(6):364-71. PubMed ID: 18410312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of microsatellite instability determined by immunohistochemical staining of hMSH2 and hMSH6 in urothelial carcinoma of the bladder.
    Mylona E; Zarogiannos A; Nomikos A; Giannopoulou I; Nikolaou I; Zervas A; Nakopoulou L
    APMIS; 2008 Jan; 116(1):59-65. PubMed ID: 18254781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of cyclooxygenase-2 in normal urothelium, and superficial and advanced transitional cell carcinoma of bladder.
    Margulis V; Shariat SF; Ashfaq R; Thompson M; Sagalowsky AI; Hsieh JT; Lotan Y
    J Urol; 2007 Mar; 177(3):1163-8. PubMed ID: 17296438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined analysis of cyclooxygenase-2 expression with p53 and Ki-67 in nonsmall cell lung cancer.
    Tsubochi H; Sato N; Hiyama M; Kaimori M; Endo S; Sohara Y; Imai T
    Ann Thorac Surg; 2006 Oct; 82(4):1198-204. PubMed ID: 16996907
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic significance of replication protein A (RPA) expression levels in bladder urothelial carcinoma.
    Levidou G; Gakiopoulou H; Kavantzas N; Saetta AA; Karlou M; Pavlopoulos P; Thymara I; Diamantopoulou K; Patsouris E; Korkolopoulou P
    BJU Int; 2011 Jul; 108(2 Pt 2):E59-65. PubMed ID: 21062395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Expression of cyclooxygenase-2 in bladder transitional cell carcinoma and the significance thereof].
    Yu L; Chen XJ; Shi PQ; Ding Q; Sun CH; Liu GB; Shi DM; Huang YG
    Zhonghua Yi Xue Za Zhi; 2008 Oct; 88(38):2683-4. PubMed ID: 19080686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of EIF-5A2 is an independent predictor of outcome in patients of urothelial carcinoma of the bladder treated with radical cystectomy.
    Chen W; Luo JH; Hua WF; Zhou FJ; Lin MC; Kung HF; Zeng YX; Guan XY; Xie D
    Cancer Epidemiol Biomarkers Prev; 2009 Feb; 18(2):400-8. PubMed ID: 19155439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclooxygenase-1 and -2 expression in urothelial carcinomas of the urinary bladder in cows.
    Borzacchiello G; Ambrosio V; Galati P; Perillo A; Roperto F
    Vet Pathol; 2003 Jul; 40(4):455-9. PubMed ID: 12824517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lymphovascular invasion in transurethral resection specimens as predictor of progression and metastasis in patients with newly diagnosed T1 bladder urothelial cancer.
    Cho KS; Seo HK; Joung JY; Park WS; Ro JY; Han KS; Chung J; Lee KH
    J Urol; 2009 Dec; 182(6):2625-30. PubMed ID: 19836779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TGF-betaRII, BAX, IGFIIR, caspase-5, hMSH3 and hMSH6 alterations are not associated with microsatellite instability or p53 mutations in invasive urothelial carcinoma of the urinary bladder.
    Saetta AA; Korkolopoulou P; Karlou M; Levidou G; Goudopoulou A; Thymara I; Stamatelli A; Tzivras M; Michalopoulos NV; Thomas-Tsagli E; Patsouris E
    Pathology; 2007 Aug; 39(4):425-32. PubMed ID: 17676485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of inducible nitric oxide synthase and cyclooxygenase-2 in angiogenesis and clinical outcome of human gastric cancer.
    Chen CN; Hsieh FJ; Cheng YM; Chang KJ; Lee PH
    J Surg Oncol; 2006 Sep; 94(3):226-33. PubMed ID: 16900533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of apoptosis-related markers in urothelial cancer of the upper urinary tract.
    Jeong IG; Kim SH; Jeon HG; Kim BH; Moon KC; Lee SE; Lee E
    Hum Pathol; 2009 May; 40(5):668-77. PubMed ID: 19157504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of uroplakin III expression is associated with a poor prognosis in patients with urothelial carcinoma of the upper urinary tract.
    Ohtsuka Y; Kawakami S; Fujii Y; Koga F; Saito K; Ando N; Takizawa T; Kageyama Y; Kihara K
    BJU Int; 2006 Jun; 97(6):1322-6. PubMed ID: 16686732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peroxisome proliferator-activated receptor gamma expression in urothelial carcinomas of the bladder: association with differentiation, proliferation and clinical outcome.
    Mylona E; Giannopoulou I; Diamantopoulou K; Bakarakos P; Nomikos A; Zervas A; Nakopoulou L
    Eur J Surg Oncol; 2009 Feb; 35(2):197-201. PubMed ID: 18513919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.